滚动资讯
FierceBiotechPremier Radiology acquires teleradiology specialist GLOBISFierceBiotech‘Portfolio assessment’ prompts Ferring to terminate 2 fertility trialsFierceBiotechUK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investmentsEndpoints NewsTrump signs order to put 100% pharma tariffs on drugs, countries without trade dealsScienceHow fast is the universe expanding? Cosmic ‘illusions’ may hold answerEndpoints NewsAspect Biosystems gets $79M from Canadian government for diabetes cell therapyLonza NewsFormulating Plant-Based and Organic Supplements: A Conversation with Lonza CHI - Nutritional OutlookEndpoints NewsDOJ weighs in favor of pharma on 340B disputeEndpoints NewsThe peptide fad lures health techIlluminaUPC refuses early knockout in Illumina–Element dispute - Life Sciences Intellectual Property ReviewBioPharma DiveImmunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJMCellComplete biosynthesis of nicotine
Endpoints News 2026年4月2日

DOJ weighs in favor of pharma on 340B dispute

DOJ weighs in favor of pharma on 340B dispute

原文
暂时没有全文，请查看原始来源。

目录

59 全部